Market Overview

Glaucoma Surgery Devices Industry 2020-2025: Anticipated to Exhibit a CAGR of 6.5% Over the Forecast Period

Share:

Dublin, Aug. 04, 2020 (GLOBE NEWSWIRE) -- The "Glaucoma Surgery Devices Market - Growth, Trends, and Forecasts (2020-2025)" report has been added to ResearchAndMarkets.com's offering.

The Global Glaucoma Surgery Devices Market is expected to register a CAGR of 6.5% during the forecast period.

This is attributing to the rising prevalence of glaucoma, increasing geriatric population, growing adoption of surgical treatments for glaucoma. In addition, the rising demand for minimally invasive procedures associated with glaucoma is also expected to trigger the growth of the market. As these procedures give benefits like reduced surgery time, faster recovery, affordability, and low risk of complications thus driving the market.

As per the report published by the American Academy of Ophthalmology (AAO) the global prevalence of glaucoma was estimated to 64.3 in 2013 and expected to reach 76 million by 2020. Furthermore, favorable reimbursements policies, rising government initiatives and improvement in the healthcare around developing countries are also expected to boost the glaucoma surgery devices market.

Key Market Trends

Minimal Invasive Glaucoma Surgery Estimated to Witness Healthy Growth

Minimal Invasive Glaucoma Surgery is expected to witness healthy growth in the future which is attributed to an increasing number of cataract surgeries and glaucoma surgeries. These devices are extensively used in the surgeries due to their long procedural volume. Moreover product approvals associated with glaucoma surgery devices are also expected to boost the segment growth.

Glaukos Corporation received FDA approval for iStent, a type of minimally invasive glaucoma surgery drainage device used in cataract surgeries. In addition another company Ivantis also received approval for Hydrus Microstent (MIGS device) I 2018. These devices are efficient in glaucoma surgeries thus results in propelling the segment growth

In addition, with the increasing number of glaucoma patients across the globe is leading to high demand for glaucoma surgery devices and thus propelling the overall market.

North America Expected to Hold a Significant Share Over the Forecast Period

North America expected to hold a significant market share in the global Glaucoma Surgery Devices Market due to the increasing prevalence of glaucoma, rising geriatric population, increasing awareness, favorable reimbursements policies and the presence of several major players.

As per a report published by Glaucoma Research Foundation in 2018 an estimate of 3 million people is having glaucoma and the number will be going to increase in the coming years. Moreover, the growing number of geriatric populations in the United States is likely to more prone to have glaucoma. Furthermore, increasing healthcare expenditure and the presence of well-established healthcare infrastructure is also fueling the growth of the overall regional market to a large extent.

Competitive Landscape

The Glaucoma Surgery Devices Market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Abbott Laboratories, Lumenis, Alcon, Glaukos Corporation, ASICO, Katalyst Surgical, Allergan, Ziemer Ophthalmic Systems, and Carl Zeiss Meditec.

Key Topics Covered

1 INTRODUCTION
1.1 Study Assumptions
1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Glaucoma
4.2.2 Increasing Geriatric Population
4.2.3 Growing Adoption of Surgical Treatments for Glaucoma
4.3 Market Restraints
4.3.1 Availability of Alternative Treatment Methods
4.4 Porter's Five Force Analysis

5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Glaucoma Drainage Device
5.1.2 Laser System
5.1.3 Punches
5.1.4 Probes
5.1.5 Others
5.2 By Surgery Method
5.2.1 Traditional Glaucoma Surgery
5.2.2 Minimal Invasive Glaucoma Surgery
5.2.3 Laser Surgery
5.3 By End User
5.3.1 Hospitals
5.3.2 Ophtalmic Clinics
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.2 Europe
5.4.3 Asia-Pacific
5.4.4 Middle-East and Africa
5.4.5 South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories Inc.
6.1.2 Lumenis
6.1.3 Alcon
6.1.4 Glaukos Corporation
6.1.5 ASICO, LLC
6.1.6 Katalyst Surgical, LLC
6.1.7 Allergan
6.1.8 Ziemer Ophthalmic Systems
6.1.9 Carl Zeiss Meditec

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

For more information about this report visit https://www.researchandmarkets.com/r/cgugbp

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

Primary Logo

View Comments and Join the Discussion!
 

Latest Ratings

StockFirmActionPT
TSLACitigroupMaintains137.0
SPOTDeutsche BankMaintains250.0
AMZNDeutsche BankMaintains4,050.0
DOCUBairdInitiates Coverage On280.0
ASOGuggenheimInitiates Coverage On17.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com